国仪量子科创板IPO获受理；史上首次“太空轨道大模型训练”完成；浙江省脑机接口重大科技专项与创新联合体将开启——《投资早参》

Market News - US stock indices closed mixed, with the Dow Jones up 1.34%, the Nasdaq down 0.25%, and the S&P 500 up 0.21%. Major tech stocks mostly declined, with Oracle down over 10%, Google down over 2%, and Tesla and Nvidia down over 1% [1] - International oil prices fell, with WTI crude down 0.96% at $57.91 per barrel and Brent crude down 1.01% at $61.58 per barrel. In contrast, international gold prices rose, with spot gold up 1.06% at $4273.16 per ounce and COMEX gold futures up 1.87% at $4303.9 per ounce [1] - European stock indices closed higher, with Germany's DAX up 0.68%, France's CAC40 up 0.79%, and the UK's FTSE 100 up 0.49% [1] Industry Insights - Starcloud, a startup, successfully trained a large language model in space using Nvidia's H100 and plans to build a 5 GW solar-powered orbital data center. The CEO stated that energy costs for the orbital data center could be 10 times lower than ground-based centers [2] - The satellite communication industry is expected to exceed 200-400 billion yuan by 2030, with an annual compound growth rate of 10%-28%. The industry is at a critical turning point from "concept validation" to "scale application" [3] - Guoyi Quantum Technology's IPO was accepted, aiming to raise 1.17 billion yuan for high-end scientific instrument industrialization and quantum technology research. The company has 129 patents related to its main business [3] - The quantum computing industry is expected to reach a market size of hundreds of billions by 2025-2030, driven by technological breakthroughs and market demand. Key stocks include Keda Guokai and Deep Technology [4] - The "Intelligent Connection Future" Brain-Computer Interface International Conference will be held, focusing on the establishment of a brain-computer interface industry cluster and the initiation of international standards for the technology [5] - The global brain-computer interface medical application market is projected to reach $40 billion by 2030 and $145 billion by 2040, with significant potential in treating neurological disorders [6]